Evaxion A/S (EVAX.US) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec6

Evaxion A/S presents preclinical data for its AML vaccine candidate EVX-04

19:00

Nov7

Evaxion A/S Presents New Findings of Personalized Cancer Vaccine at the SITC Annual Meeting

22:32

Lake Street Maintains Buy Rating on Evaxion Biotech with a $11 Target Price

16:23

Nov6

Evaxion A/S released FY2025 Q3 earnings on November 6 Pre-Market EST, actual revenue USD 7.492 M (forecast USD 2.5 M), actual EPS USD 0.726 (forecast USD -0.01)

14:30

Evaxion A/S released FY2025 9 Months earnings on November 6, Pre-Market EST, actual revenue USD 7.529M, actual EPS USD -0.5599

14:30

Nov3

Evaxion A/S's Cancer Vaccine EVX-04 Shows Promising Preclinical Results in AML Treatment

14:00

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 7.492 M, Net Income 4.618 M, EPS 0.726

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 37 K, Net Income -4.831 M, EPS -1

May27

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -1.58 M, EPS -0.2859

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change